neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...
neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...
NEW RECOMMENDATIONS for administering epinephrine during acute allergic reactions (AAR) will enable patients, medical practitioners, and importantly non-medical personnel to improve AAR recognition, ...
Hosted on MSN
Nasus Pharma highlights transformational 2025 as NS002 intranasal epinephrine program advances and IPO completes
An announcement from Nasus Pharma Ltd. ( (NSRX)) is now available. On December 22, 2025, Nasus Pharma Ltd. released a shareholder letter from CEO Dan Teleman highlighting a transformational year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback